June 11, 2026: Harnessing Qualitative Methods in Pragmatic Trials: An Interview With Emily O’Brien and David Chambers

Qualitative methods can bring additional dimensions to pragmatic research to help study teams better understand participants’ experiences, improve recruitment and retention, and contextualize study results. At the NIH Collaboratory’s 2026 Annual Steering Committee Meeting, we spoke with Emily O’Brien and David Chambers about the ways researchers can use qualitative methods to enhance pragmatic trials.

“It’s been really fun to see all the different ways the investigators [for the NIH Collaboratory Trials] have incorporated qualitative methods to complement the other kinds of methods they use in their studies,” said O’Brien, an associate professor of population health sciences at Duke University and cochair of the NIH Collaboratory’s Patient Centered Outcomes Core.

O’Brien highlighted the experience of the MOMs Chat & Care Study, in which the research team used narrative interviews, a method of qualitative data collection that asks participants to produce in-depth stories to describe their experiences.

“This is going to be really helpful in contextualizing the results and trying to understand better which populations the intervention works well for and, if they can improve the intervention in the future, what that might look like,” O’Brien said.

Go to the full video.

“One of the main challenges in integrating qualitative data into pragmatic clinical trials is that there are so many ways you can use qualitative data,” said Chambers. Chambers is deputy director for implementation science at the National Cancer Institute.

“You can use it to refine an intervention, to understand the results better, to improve your recruitment strategies,” he said, “so it’s really about prioritization and trying to figure out how to identify the highest-value opportunities to collect those data and make sure the study is informed by whatever you’re finding from the qualitative data.”

Go to the full interview.

In the coming weeks, we will share more highlights from the 2026 Annual Steering Committee Meeting. Access the complete meeting materials.

Video still from an interview with Dr. Emily O'Brien and Dr. David Chambers
Dr. Emily O’Brien and Dr. David Chambers

 

August 3, 2023: NCI’s David Chambers Discusses Role of Implementation Science in Pragmatic Research

This year’s Annual Steering Committee Meeting for the NIH Pragmatic Trials Collaboratory featured implementation science as one of the topics of focus. In an interview after his keynote presentation, Dr. David Chambers, deputy director for implementation science at the National Cancer Institute, shared his thoughts on opportunities for implementation science in the context of pragmatic trials.

Why Implementation Science Is Important in Pragmatic Research

Chambers described the overlap between implementation science and pragmatic research and how this creates several benefits. Implementation science gives a heightened focus on how to get interventions to be as accessible, well used, and beneficial as possible to populations within the systems and communities in which people are seeking and receiving healthcare.

“The earlier researchers can think about their interventions being used beyond the trial, the better,” Chambers explained. “Implementation science helps to provide a lens for multiple levels of change that may be needed, including supports for patients and families, clinicians, clinics, systems, policymakers, and other key decision-makers.”

Furthermore, implementation science methods can save time in identifying barriers and facilitators for delivering interventions with high quality-knowledge which can be applied toward the ultimate use of interventions.

Chambers encourages researchers to embrace the dynamism that is reflected in our health systems, which is particularly apt for research conducted in the setting of routine care. “It is a given that there will be deviations from the design of an intervention and its implementation, so how can researchers learn from this?” he said.

In terms of sustaining an intervention, a more dynamic approach is needed to how the intervention and the context will change over time, he explained. “Too often we think of sustainment in terms of fixing things in their original state. Sustainment needs to think about how to build in evolution-medicine and our practices are evolving.”

Role of the NIH Pragmatic Trials Collaboratory

According to Chambers, the NIH Pragmatic Trials Collaboratory provides a natural setting for implementation activities because of the close partnerships between the investigative teams and the health systems and community settings where the research occurs. As a result, the program is poised for ongoing learning from the strategies health systems are using to implement a range of different interventions.

There is also an opportunity for pooling lessons across the NIH Collaboratory Trials, such as common measures that can be used to better characterize adaptation, understanding perspectives and needs of patients and clinicians, and approaches related to long-term sustainment or deimplementation of interventions.

Increasingly for NIH Collaboratory trials, issues related to implementation are baked into both the design of interventions and the approach used to test the interventions, which is a testament to the program’s ongoing progress in encouraging the use of implementation science concepts and methods.

Learn more about the NIH Collaboratory’s Implementation Science Core.

How NIH Is Advancing Implementation Science

For over 20 years, NIH has recognized the gaps in knowledge needed for successful implementation of evidence-based interventions. Across NIH institutes, centers, and offices, they have discussed the common challenges observed when investigators saw a positive result in their trial and were frustrated that it could not be replicated and scaled up in the real world.

NIH funds dissemination and implementation research grants and has a standing review panel, the Science of Implementation in Health and Healthcare, focused on this area where any applicant to NIH can suggest that their grant be reviewed. In addition, NIH supports training opportunities in the field and cohosts an annual scientific conference in partnership with AcademyHealth.

NIH continues to explore the interface between effectiveness and implementation, think about deimplementation, and work on tackling misinformation, all towards advancing how to better apply the evidence generated in research to optimize population health and healthcare.

Podcast August 2, 2021: Diversity Workshop Series: Increasing Diversity in Pragmatic Clinical Trials (Dr. Boineau, Dr. Chambers, Dr. Curtis, Dr. O’Brien, Dr. Weber, Dr. Zimmerman)

This podcast summarizes the series on ‘Inclusion of Diverse Participants in Pragmatic Clinical Trials’ with a panel discussion with Dr. Robin Boineau, Dr. David Chambers, Dr. Lesley Curtis, Dr. Emily O’Brien, Dr. Wendy Weber, and Dr. Kanecia Zimmerman.

Click on the recording below to listen to the podcast.

Want to hear more? View the full Diversity workshop series Grand Rounds presentation from

May 14, 2021;  June 4, 2021; June 25, 2021; July 16, 2021; and July 30, 2021.

For alerts about new episodes, subscribe free on Apple Podcasts or SoundCloud.

Read the transcript.

July 13, 2021: Diversity Workshop Continues With Lessons From Implementation Trials

The NIH Collaboratory is using its popular ePCT Grand Rounds platform for a special webinar series on diversity in pragmatic clinical trials.

In this Friday’s session—“Maximizing Diversity in PCTs – What Can We Learn From Implementation Trials?”—Dr. David Chambers of the National Cancer Institute (NCI) will facilitate a discussion about lessons from implementation science for maximizing participant diversity in pragmatic clinical trials. Dr. Chambers is deputy director for implementation science in the Office of the Director in the NCI’s Division of Cancer Control and Population Sciences.

The panelists will include:

  • Dr. Amanda Midboe of the US Department of Veterans Affairs, chair of the Implementation Science Work Group for the NIH-DOD-VA Pain Management Collaboratory
  • Dr. Anne Trontell, associate director in the Clinical Effectiveness and Decision Science Program at the Patient-Centered Outcomes Research Institute (PCORI)

The Grand Rounds session will be held on Friday, July 16, at 1:00 pm eastern. Join the online meeting.

Other upcoming sessions in the diversity workshop series include:

All sessions are free and open to the public; no registration is required. Recordings will be archived on the Grand Rounds website.

Headshots of Drs. David Chambers, Amanda Midboe, and Anne Trontell
Left to right: Drs. David Chambers, Amanda Midboe, and Anne Trontell